BioMed Central home | Journals A-Z | Feedback | My details

Comments

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal

Thomas A Faunce

Australia and New Zealand Health Policy 2007, 4:9doi:10.1186/1743-8462-4-9

No comments have been made on this article


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.